Philips Announces Its 2026–2028 Growth Strategy

On February 10, 2026, Royal Philips unveiled its new 2026–2028 strategic growth plan during its Capital Markets Day in London, United Kingdom, marking an important milestone in the company's transformation into a focused global healthcare technology leader. Under the leadership of Chief Executive Officer Roy Jakobs, Philips introduced a strategy centered on healthcare innovation, artificial intelligence, platform-based solutions, disciplined execution, and profitable growth. The company identified three strategic priorities: developing targeted growth strategies for each business segment, accelerating innovation, and maintaining strong operational discipline. Philips also announced financial targets, including mid-single-digit annual comparable sales growth over the three-year period and a mid-teens adjusted EBITA profit margin by 2028. These objectives reflected the company's ambition to strengthen its competitive position while delivering advanced healthcare and personal health solutions. The 2026–2028 strategy represents a significant new chapter in Philips' evolution as a global leader in healthcare technology. Building on its previous transformation efforts, the company outlined plans to expand AI-enabled healthcare platforms, strengthen diagnostic imaging and image-guided therapy, advance connected patient monitoring, and develop innovative personal health products. Philips emphasized integrating medical hardware, software, data, and artificial intelligence to support more efficient clinical workflows and personalized patient care. The company also targeted approximately €4.5 billion to €5 billion in cumulative free cash flow over the three-year period, alongside improvements in productivity and profitability. These ambitions reflected Philips' commitment to sustainable growth, technological innovation, and delivering long-term value to healthcare providers, patients, consumers, and shareholders. The February 2026 announcement established an important roadmap for the company's next phase of growth through 2028.